TY  - CONF

T1  - Abstract CT035: <i>TP53</i> abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia

JO  - Cancer Research

UR  - https://doi.org/10.1158/1538-7445.am2020-ct035

PY  - 2020/08/15

AU  - Vadakekolathu J

AU  - Lai C

AU  - Reeder S

AU  - Church SE

AU  - Hood T

AU  - Muth J

AU  - Altmann H

AU  - Ciciarello M

AU  - Curti A

AU  - Valk PJ

AU  - Löwenberg B et al

ED  - 

DO  - DOI: 10.1158/1538-7445.am2020-ct035

PB  - American Association for Cancer Research (AACR)

VL  - 80

IS  - 16_Supplement

SP  - CT035

EP  - CT035

Y2  - 2026/02/25

ER  -